Item
Cantab Dextrose SPECIALTY DEXTROSE FOR FOOD (Cantab)
A unique, spherical dextrose that enables food processors to reduce energy costs for the production of finished goods.
US - FDA: Dextrose
Canada - Health Canada: Dextrose
Kosher
Halal
GRAS
Food Ingredient
Attributes
- Gluten-free
- Halal
- Ingredient declaration
- Kosher
- PHO-free
- Ready-to-Eat (RTE)
- Vegan
Features & benefits
- Dairy-free
- Ethically Produced
- Locally Produced
- Made/Grown in the USA
- Plant-based
- Sustainably Produced
- Vegetarian
Locations
| Location name | Address |
|---|---|
| J. Rettenmaier USA LP - JRS Pharma LP | 725 41st Drive SW Cedar Rapids, IA 52404 |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Allergens EU/UK | J. Rettenmaier USA LP - JRS Pharma LP | Allergens EU/UK.pdf | 3/21/2024 | 3/21/2026 |
| Allergens | J. Rettenmaier USA LP - JRS Pharma LP | Allergens.pdf | 5/17/2024 | 5/17/2026 |
| Label Sample | J. Rettenmaier USA LP - JRS Pharma LP | Cantab - 50 LB.png | 11/1/2024 | 11/1/2025 |
| Animal Testing Statement | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/31/2023 | 3/30/2025 |
| BSE - TSE | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/31/2023 | 3/30/2026 |
| EtO Statement | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/31/2023 | 3/30/2025 |
| GMO | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/31/2023 | 3/30/2025 |
| GRAS/NDI/ODI Statement | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/31/2023 | 3/30/2026 |
| Heavy Metal | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/31/2023 | 3/30/2025 |
| Ingredient Statement | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/21/2024 | 3/21/2025 |
| Irradiation Status Statement | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/31/2023 | 3/30/2025 |
| Melamine | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/21/2024 | 3/21/2025 |
| Natural | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/21/2024 | 3/21/2025 |
| Pesticide | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/31/2023 | 3/30/2025 |
| Residual Statement | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/21/2024 | 3/21/2025 |
| Sewage Statement | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/31/2023 | 3/30/2025 |
| Vegan/Vegetarian Statement | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/31/2023 | 3/30/2025 |
| WADA/NSF/NFL Statement | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/31/2023 | 3/30/2025 |
| Gluten | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/21/2024 | 3/21/2025 |
| No Animal Ingredient Statement | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/21/2024 | 3/21/2025 |
| Phthalate Esters Letter | J. Rettenmaier USA LP - JRS Pharma LP | Cantab Dextrose - PRI-23378-17 (7).pdf | 3/21/2024 | 3/21/2025 |
| Country of Origin EU/UK | J. Rettenmaier USA LP - JRS Pharma LP | Country of Origin EU/UK.pdf | 4/21/2022 | 4/20/2025 |
| Country of Origin | J. Rettenmaier USA LP - JRS Pharma LP | Country of Origin.pdf | 5/17/2024 | 5/17/2027 |
| CoA Sample | J. Rettenmaier USA LP - JRS Pharma LP | CTS23J36C Cantab Dextrose.pdf | 12/21/2023 | 12/20/2025 |
| Dietary Supplement Questionnaire | J. Rettenmaier USA LP - JRS Pharma LP | Dietary Supplement Questionnaire.pdf | 5/17/2024 | 5/17/2025 |
| HARPC Food Safety Plan (Item) | J. Rettenmaier USA LP - JRS Pharma LP | FSMA Compliance Statement-9858-11.pdf | 1/5/2024 | 1/4/2027 |
| FSVP Assessment Form | J. Rettenmaier USA LP - JRS Pharma LP | FSVP Assessment Form.pdf | 5/17/2024 | 5/17/2025 |
| HACCP | J. Rettenmaier USA LP - JRS Pharma LP | HACCP Statement- JRS USA-2023-9 4.pdf | 2/3/2022 | 2/2/2025 |
| Halal | J. Rettenmaier USA LP - JRS Pharma LP | Halal Pharma (DEX) - 8.31.2025.pdf | 8/16/2024 | 8/31/2025 |
| Item Questionnaire | J. Rettenmaier USA LP - JRS Pharma LP | Item Questionnaire.pdf | 5/17/2024 | 5/17/2027 |
| Kosher | J. Rettenmaier USA LP - JRS Pharma LP | Kosher Cantab - 8.31.2025.pdf | 8/16/2024 | 8/31/2025 |
| Lot Code | J. Rettenmaier USA LP - JRS Pharma LP | Lot Number Code Interpretation-2024-22.pdf | 12/17/2024 | 12/17/2027 |
| National Bioengineered Food Disclosure Standard (Simplified) | J. Rettenmaier USA LP - JRS Pharma LP | National Bioengineered Food Disclosure Standard (Simplified).pdf | 5/17/2024 | 5/17/2027 |
| Nutrition EU/UK | J. Rettenmaier USA LP - JRS Pharma LP | Nutrition EU/UK.pdf | 4/21/2022 | 4/20/2025 |
| Nutrition | J. Rettenmaier USA LP - JRS Pharma LP | Nutrition.pdf | 5/17/2024 | 5/17/2027 |
| Food Contact Packaging Certificate of Compliance | J. Rettenmaier USA LP - JRS Pharma LP | Packaging Materials and Storage Statement- JRUSA Products -7209-11.pdf | 1/18/2023 | 1/17/2025 |
| HACCP Process Flow Diagram | J. Rettenmaier USA LP - JRS Pharma LP | Process Flowchart- Cantab Dextrose-32592-1 (2).pdf | 3/14/2023 | 3/13/2025 |
| California Prop. 65 | J. Rettenmaier USA LP - JRS Pharma LP | Proposition 65 Statement- Cantab- Dextrose-4559-12.pdf | 11/1/2024 | 11/1/2026 |
| Safety Data Sheet (SDS) | J. Rettenmaier USA LP - JRS Pharma LP | Safety Data Sheet- Cantab and Cantab Non-GMO Dextrose-2246-11.pdf | 10/7/2024 | 10/7/2027 |
| Suitability Requirements | J. Rettenmaier USA LP - JRS Pharma LP | Suitability Requirements.pdf | 5/17/2024 | 5/17/2027 |
| Product Specification Sheet | TDS- CANTAB Dextrose-3882-15 (8).pdf | 5/31/2024 | 5/31/2027 | |
| Product Specification Sheet | J. Rettenmaier USA LP - JRS Pharma LP | TDS- CANTAB Dextrose-3882-15 (8).pdf | 6/16/2023 | 6/15/2026 |
| Shelf Life | J. Rettenmaier USA LP - JRS Pharma LP | TDS- CANTAB Dextrose-3882-15 (8).pdf | 6/16/2023 | 6/15/2026 |
